NGeneBio Raises $11M

NEW YORK (GenomeWeb) – Korean diagnostics firm NGeneBio said this week that it recently closed an $11 million Series B financing. The company also achieved a CE-IVD mark for its HEMEaccuTest, which targets hematological malignancies, according to YoungJoon Moon, director of business development for the Seoul-based company. NGeneBio’s new financing builds on the $1.9 million…

AACC 2018 Chicago

AACC is AMERICAN ASSOCIATION FOR CLINICAL CHEMISTRY. AACC 2018 is organizing their 70th Annual Scientific Meeting from 29 July to 2 Aug. AACC The outstanding event in Medical and Chemistry category will be the center of attention to Laboratory Management, Mass Spectrometry, Clinical Chemistry, Molecular Diagnostics, Laboratory Medicine and Translational Medicine areas. American Association for…

2018 FIME (Florida International Medical Exhibition)

  FIME 2018 – Florida International Medical Expo – Orlando, FL July 17, 2018 – July 19, 2018 Orange County Convention Center 9800 International Dr, Orlando, FL 32819, USA The 2018 Florida International Medical Expo will be held July 17-19 in Orlando, Fla. The annual FIME Expo is an opportunity for medical equipment professionals to…

MEDLAB Dubai, 2018 – NGeneBio at Z6.A31

Booth Stand No. Z6.A31 https://www.medlabme.com/en/overview/show-information.html <Show Information> 600 EXHIBITORS 40 EXHIBITING COUNTRIES 16 COUNTRY PAVILIONS 25,000 ATTENDEES 6,500 DELEGATES 17 CONFERENCES MEDLAB is the flagship exhibition and congress of the MEDLAB Series portfolio, a collection of leading laboratory and diagnostics exhibitions and conferences worldwide, spanning across the Middle East, Asia, East/West Africa, Europe and the…

NGeneBio Receives CE Mark for BRCA Test Panel and Data Analysis Software

NGeneBio Receives CE Mark for BRCA Test Panel and Data Analysis Software Regulatory Roundup: September 2017 Date: SEP.1.2017  // Source: Clinical Laboratory News Topics:  Cancer and Tumors, Genetics and Genomics Disorders, Government and Regulatory NGeneBio, a molecular diagnostics startup based in Seoul, South Korea, received the CE mark for BRCAaccuTest and NGeneAnalySys, two next-generation sequencing (NGS) based products that…